Published in J Pediatr on September 01, 1985
Congenital diaphragmatic hernia. Orphanet J Rare Dis (2012) 1.40
Congenital diaphragmatic hernia: influence of associated malformations on survival. Arch Dis Child (1993) 1.38
Detrimental effects of standard medical therapy in congenital diaphragmatic hernia. Ann Surg (1999) 1.23
Adult outcome of congenital lower respiratory tract malformations. Thorax (2001) 1.17
The long-term follow-up of patients with a congenital diaphragmatic hernia: a broad spectrum of morbidity. Pediatr Surg Int (2008) 1.15
Congenital diaphragmatic hernia: current status and review of the literature. Eur J Pediatr (2008) 1.12
Congenital diaphragmatic hernia: endothelin-1, pulmonary hypertension, and disease severity. Am J Respir Crit Care Med (2010) 1.09
Significance of pulmonary artery size and blood flow as a predictor of outcome in congenital diaphragmatic hernia. Pediatr Surg Int (2008) 0.99
Preoperative stabilisation in congenital diaphragmatic hernia. Arch Dis Child (1986) 0.97
Enhanced expression of vascular endothelial growth factor in lungs of newborn infants with congenital diaphragmatic hernia and pulmonary hypertension. Thorax (1999) 0.94
Bilateral congenital diaphragmatic hernia and gastroschisis in a newborn: can low intrathoracic pressure prevent the pulmonary hypoplasia? Pediatr Surg Int (2007) 0.87
Delayed surgical repair and ECMO improves survival in congenital diaphragmatic hernia. Ann Surg (1992) 0.86
Management of pulmonary hypertension in congenital diaphragmatic hernia: nitric oxide with prostaglandin-E1 versus nitric oxide alone. Pediatr Surg Int (2008) 0.86
Quantitative pulmonary perfusion imaging at 3.0 T of 2-year-old children after congenital diaphragmatic hernia repair: initial results. Eur Radiol (2012) 0.83
Increased levels of circulating adhesion molecules in neonates with congenital diaphragmatic hernia complicated by persistent pulmonary hypertension. Pediatr Surg Int (2003) 0.82
Congenital diaphragmatic hernia: impact of prostanoids in the perioperative period. Arch Dis Child (1990) 0.82
Effect of dexamethasone on endothelial nitric oxide synthase in experimental congenital diaphragmatic hernia. Arch Dis Child Fetal Neonatal Ed (1998) 0.82
ANG-1 TIE-2 and BMPR signalling defects are not seen in the nitrofen model of pulmonary hypertension and congenital diaphragmatic hernia. PLoS One (2012) 0.81
Defective pulmonary innervation and autonomic imbalance in congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol (2011) 0.81
Defective parasympathetic innervation is associated with airway branching abnormalities in experimental CDH. Am J Physiol Lung Cell Mol Physiol (2015) 0.79
B-type natriuretic peptide: prognostic marker in congenital diaphragmatic hernia. Pediatr Res (2014) 0.79
Serum monocyte chemotactic protein-1 levels in congenital diaphragmatic hernia. Pediatr Surg Int (2007) 0.78
Immunohistochemical distribution of bombesin-positive pulmonary neuroendocrine cells in a congenital diaphragmatic hernia. Surg Today (1999) 0.78
Acute effect of a dual ETA-ETB receptor antagonist on pulmonary arterial vasculature in preterm lamb fetuses with surgically induced diaphragmatic hernia. Pediatr Surg Int (2010) 0.78
Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia. J Pediatr Surg (2013) 0.78
Increased contractility and impaired relaxation of the left pulmonary artery in a rabbit model of congenital diaphragmatic hernia. Pediatr Surg Int (2012) 0.76
Prevention of pulmonary hypoplasia and pulmonary vascular remodeling by antenatal simvastatin treatment in nitrofen-induced congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol (2015) 0.76
Fetal surgery. West J Med (1993) 0.76
Making the most out of the least: new insights into congenital diaphragmatic hernia. Thorax (1997) 0.75
Persistent pulmonary hypertension of the newborn: a review. Med J Armed Forces India (2011) 0.75
Antenatal BAY 41-2272 reduces pulmonary hypertension in the rabbit model of congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol (2016) 0.75
Lung hypoplasia in newborn rabbits with a diaphragmatic hernia affects pulmonary ventilation but not perfusion. Pediatr Res (2017) 0.75
Combined antenatal therapy with retinoic acid and tracheal occlusion in a rat model of congenital diaphragmatic hernia. Pediatr Surg Int (2016) 0.75
Congenital diaphragmatic hernias: from genes to mechanisms to therapies. Dis Model Mech (2017) 0.75
Tissue engineering. Science (1993) 19.65
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med (1996) 8.02
Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med (1993) 4.91
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials (2003) 3.63
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics (1989) 3.38
Transplantation of chondrocytes utilizing a polymer-cell construct to produce tissue-engineered cartilage in the shape of a human ear. Plast Reconstr Surg (1997) 2.93
Results of anterograde transcatheter closure of patent ductus arteriosus using single or multiple Gianturco coils. Am J Cardiol (1994) 2.91
Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med (1991) 2.88
Stimulation of neurite outgrowth using an electrically conducting polymer. Proc Natl Acad Sci U S A (1997) 2.74
Hepatocyte proliferation in vitro: its dependence on the use of serum-free hormonally defined medium and substrata of extracellular matrix. Proc Natl Acad Sci U S A (1984) 2.64
Bioengineered teeth from cultured rat tooth bud cells. J Dent Res (2004) 2.31
Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. Biomaterials (1996) 2.27
Tuberculosis in eastern Europe and the former Soviet Union: how concerned should we be? Lancet (1994) 2.23
Outcome and assessment after the modified Fontan procedure for hypoplastic left heart syndrome. Circulation (1992) 2.15
Pulmonary AV malformations after superior cavopulmonary connection: resolution after inclusion of hepatic veins in the pulmonary circulation. Ann Thorac Surg (1997) 2.09
Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Primary Pulmonary Hypertension Study Group. Circulation (1997) 2.03
The liver as a stem cell and lineage system. Am J Physiol (1992) 2.02
Lung biopsy in congenital heart disease: a morphometric approach to pulmonary vascular disease. Circulation (1978) 1.97
The pulmonary vascular lesions of the adult respiratory distress syndrome. Am J Pathol (1983) 1.88
In vitro and in vivo degradation of porous poly(DL-lactic-co-glycolic acid) foams. Biomaterials (2000) 1.85
Connective tissue biomatrix: its isolation and utilization for long-term cultures of normal rat hepatocytes. J Cell Biol (1980) 1.84
Clonogenic hepatoblasts, common precursors for hepatocytic and biliary lineages, are lacking classical major histocompatibility complex class I antigen. Proc Natl Acad Sci U S A (2000) 1.84
Mechanism of rejection of virus persistently infected tumor cells by athymic nude mice. J Exp Med (1979) 1.81
Functional living trileaflet heart valves grown in vitro. Circulation (2000) 1.77
Creation of viable pulmonary artery autografts through tissue engineering. J Thorac Cardiovasc Surg (1998) 1.76
Transcatheter closure with single or multiple Gianturco coils of patent ductus arteriosus in infants weighing < or = 8 kg: retrograde versus antegrade approach. Am Heart J (1996) 1.75
Posttranscriptional modulation of gene expression in cultured rat hepatocytes. Mol Cell Biol (1984) 1.75
Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tissue Eng (2000) 1.71
Early fetal development of lung vasculature. Am J Respir Cell Mol Biol (1997) 1.67
Tissue engineering of complex tooth structures on biodegradable polymer scaffolds. J Dent Res (2002) 1.61
Integrin binding and cell spreading on extracellular matrix act at different points in the cell cycle to promote hepatocyte growth. Mol Biol Cell (1994) 1.61
Partial hepatectomy-induced polyploidy attenuates hepatocyte replication and activates cell aging events. Am J Physiol (1999) 1.60
Laminated three-dimensional biodegradable foams for use in tissue engineering. Biomaterials (1993) 1.57
Physicians' refusal of requested treatment. The case of Baby L. N Engl J Med (1990) 1.57
Stent implantation for relief of pulmonary artery stenosis: immediate and short-term results. Cathet Cardiovasc Diagn (1996) 1.55
Evaluation of right ventricular systolic pressure during incremental exercise by Doppler echocardiography in adults with atrial septal defect. Chest (1998) 1.54
Tissue-engineered growth of cartilage: the effect of varying the concentration of chondrocytes seeded onto synthetic polymer matrices. Int J Oral Maxillofac Surg (1994) 1.52
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges. J Biomed Mater Res (1997) 1.51
A polymer foam conduit seeded with Schwann cells promotes guided peripheral nerve regeneration. Tissue Eng (2000) 1.48
Transcatheter closure of large patent ductus arteriosus (> or = 4 mm) with multiple Gianturco coils: immediate and mid-term results. Heart (1996) 1.47
Preoperative risk-of-death prediction model in heart surgery with deep hypothermic circulatory arrest in the neonate. J Thorac Cardiovasc Surg (2000) 1.46
Prospective detection by Doppler color flow imaging of additional defects in infants with a large ventricular septal defect. J Am Coll Cardiol (1990) 1.45
Tissue engineering: the challenges ahead. Sci Am (1999) 1.45
Hypoplastic left heart syndrome: hemodynamic and angiographic assessment after initial reconstructive surgery and relevance to modified Fontan procedure. J Am Coll Cardiol (1991) 1.45
Synthetic polymers seeded with chondrocytes provide a template for new cartilage formation. Plast Reconstr Surg (1991) 1.44
Excessive anaerobic metabolism during exercise after repair of aortic coarctation. J Pediatr (1997) 1.44
Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation. J Biomed Mater Res (1993) 1.44
Tissue engineering: current state and prospects. Annu Rev Med (2001) 1.42
The structural basis of persistent pulmonary hypertension of the newborn infant. J Pediatr (1981) 1.42
Preliminary studies of tissue-engineered intestine using isolated epithelial organoid units on tubular synthetic biodegradable scaffolds. Transplant Proc (1997) 1.41
Isolated peripheral pulmonary artery stenoses in the adult. Circulation (1996) 1.39
Transposition of the great arteries with posterior aorta. Anatomic repair. J Thorac Cardiovasc Surg (1990) 1.38
Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci U S A (1981) 1.34
Contractile cardiac grafts using a novel nanofibrous mesh. Biomaterials (2004) 1.32
Tissue engineering: a 21st century solution to surgical reconstruction. Ann Thorac Surg (2001) 1.32
Involvement of gap junctions in tumorigenesis: transfection of tumor cells with connexin 32 cDNA retards growth in vivo. Proc Natl Acad Sci U S A (1991) 1.29
Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels. Ann Surg (1998) 1.29
Congenital diaphragmatic hernia--a tale of two cities: the Boston experience. J Pediatr Surg (1997) 1.28
Transhepatic central venous access for cardiac catheterization and radiologic intervention. Cathet Cardiovasc Diagn (1995) 1.28
Lung growth in health and disease. Br J Dis Chest (1984) 1.28
Myocardial ischemia due to infrarenal aortic cross-clamping during aortic surgery in patients with severe coronary artery disease. Circulation (1976) 1.27
Fetal diaphragmatic hernia: ultrasound diagnosis and clinical outcome in 38 cases. J Pediatr Surg (1989) 1.25
Proteoglycans and glycosaminoglycans induce gap junction synthesis and function in primary liver cultures. J Cell Biol (1987) 1.24
Tissue engineering by cell transplantation using degradable polymer substrates. J Biomech Eng (1991) 1.24
Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg (1995) 1.24
Extracellular matrix gradients in the space of Disse: relevance to liver biology. Hepatology (1992) 1.21
Effects of leukotrienes C4 and D4 on glycoprotein and lysozyme secretion by human bronchial mucosa. Prostaglandins (1983) 1.19
Prostacyclin and prostaglandin E1 for severe idiopathic pulmonary artery hypertension. Lancet (1980) 1.18
Inappropriate secretion of antidiuretic hormone in a postsurgical pediatric population. Crit Care Med (1983) 1.18
Bronchopulmonary dysplasia: a morphometric study with emphasis on the pulmonary vasculature. Pediatr Pathol (1984) 1.17
Culturing hepatocytes and other differentiated cells. Hepatology (1984) 1.16
Stabilized polyglycolic acid fibre-based tubes for tissue engineering. Biomaterials (1996) 1.16
Early in vivo experience with tissue-engineered trileaflet heart valves. Circulation (2000) 1.16
Structure and function in pulmonary hypertension. New perceptions. Chest (1986) 1.16
Formation of urothelial structures in vivo from dissociated cells attached to biodegradable polymer scaffolds in vitro. J Urol (1992) 1.16
Formation of phalanges and small joints by tissue-engineering. J Bone Joint Surg Am (1999) 1.15
The effects of dexamethasone on in vitro collagen gene expression. J Biol Chem (1987) 1.15
Tissue engineering of autologous aorta using a new biodegradable polymer. Ann Thorac Surg (1999) 1.15
Outcome of subcutaneous islet transplantation improved by polymer device. Transplantation (1996) 1.14
Laminin as a substrate for retinal axons in vitro. Brain Res (1984) 1.13
Studies of brush border enzymes, basement membrane components, and electrophysiology of tissue-engineered neointestine. J Pediatr Surg (1998) 1.11
Allopurinol neurocardiac protection trial in infants undergoing heart surgery using deep hypothermic circulatory arrest. Pediatrics (2001) 1.11
Pulmonary hypoplasia resulting from phrenic nerve agenesis and diaphragmatic amyoplasia. J Pediatr (1980) 1.10
Interaction of Fusarium graminearum and F. moniliforme in Maize Ears: Disease Progress, Fungal Biomass, and Mycotoxin Accumulation. Phytopathology (1999) 1.09
Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus. J Clin Invest (1983) 1.09
The 6-min walk test (6MW) as an efficacy endpoint in pulmonary arterial hypertension clinical trials: demonstration of a ceiling effect. Vascul Pharmacol (2005) 1.09
Short-term pulmonary vasodilation with L-arginine in pulmonary hypertension. Circulation (1995) 1.08
Frequency of anesthetic cardiac arrest in infants: effect of pediatric anesthesiologists. J Clin Anesth (1992) 1.08
Prevascularization of porous biodegradable polymers. Biotechnol Bioeng (1993) 1.08
Tissue engineering of heart valves: in vitro experiences. Ann Thorac Surg (2000) 1.07
Regulation of growth and differentiation of a rat hepatoma cell line by the synergistic interactions of hormones and collagenous substrata. J Cell Biol (1983) 1.07
In vitro organogenesis of liver tissue. Ann N Y Acad Sci (1997) 1.07
The structural basis of PPHN. Clin Perinatol (1984) 1.07
New pulsatile bioreactor for in vitro formation of tissue engineered heart valves. Tissue Eng (2000) 1.06
Cardiovascular physiology during fetal development and implications for tissue engineering. Tissue Eng (2001) 1.06